Pharma-Bio Serv (PBSV)

Overall impact
B (72)

Commentary

Pharma-Bio Serv is a strong overall performer. With a 'B' rating of 72.4 for overall impact (85th percentile compared to all companies), Pharma-Bio Serv ranks 10th out of 45 industry peers, behind Capgemini, Bain, BCG and 6 others, and ahead of ICF International, Wilhelmina International, RMR and 32 others. On top material causes for Pharma-Bio Serv's industry (Business Services), Pharma-Bio Serv performs well in Fair Labor Practices (95.2 score), Safety From Violent Conflict (81.7), Improved Mental Health (86.8) and 1 other cause where it received an 'A' score and performs poorly in Reduced Green House Gas Emissions (26.7 score).
Impact
Cause PBSV
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
55
Sector
Industrials
Industry
Professional Services
Sub-industry
Research & Consulting Services
SASB industry
Professional & Commercial Services
Headquarters
Pr, United States
Share classes
PBSV
Description
Pharma-Bio Serv, Inc. operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services, including regulatory compliance, validation, technology transfer, engineering, project management, and process support services. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Material causes
Ethos considers the following causes material for Pharma-Bio Serv, based on its industry sub-industry Research & Consulting Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.